Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
about
Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinomaNotch1 is a 5-fluorouracil resistant and poor survival marker in human esophagus squamous cell carcinomasEmbryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targetingTherapeutic potential of manipulating VEGF splice isoforms in oncologyInhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner.RBP-J is not required for granule neuron progenitor development and medulloblastoma initiated by Hedgehog pathway activation in the external germinal layer.Notch3 regulates the activation of hepatic stellate cells.The new biology of diabetes.Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathwayInhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis.Targeting Notch to target cancer stem cells.Acute myeloid leukemia stem cells: seek and destroy.Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties.Notch3 activation promotes invasive glioma formation in a tissue site-specific manner.Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma.Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy
P2860
Q28087059-B5C0BB78-DC1B-4B45-BFFE-2E0E60075AE1Q28486035-0504BB3F-F7F5-4A79-82D1-10BA9292054FQ30426842-61ADFCDB-46BD-4921-8A68-E370E86BB021Q33888458-2DACAA29-2AD4-47FB-9D34-B4C326CA4C36Q34205103-EA5DDE07-811C-43DF-88EC-CC71F0FFD3F1Q34273658-D5B134EA-7406-4217-BEB9-105A39257EACQ35872127-8DF5BA1D-F857-48B0-8CE6-5D0A39AC9E05Q36113537-55E1E7F4-417F-4F64-B2A2-C1702394CCFAQ36989148-6AC73148-2648-4D6B-8B00-C8CD0EE729B0Q37523472-C7AC9900-7262-410C-AD6F-E9FA85B135FEQ37763414-9D501876-D23F-4481-8517-61267FC5DD95Q37810086-2E1AB4F9-2408-42A7-B843-1D4EAE098144Q39796383-3891096A-5EF8-4517-A0ED-A9141061857AQ42239102-0A96773E-B9D1-4ED1-8C76-4D78FE33AEDCQ48224594-70AAAF27-46AE-4D47-9B9D-2092C8C0BDCFQ50790389-00FD1C5B-4D81-4507-A275-B3F07A118AA3Q57044361-6F48E216-3A66-46F2-A197-6964DE7C57E9
P2860
Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
@ast
Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
@en
type
label
Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
@ast
Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
@en
prefLabel
Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
@ast
Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
@en
P2860
P1476
Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
@en
P2093
Benjamin Purow
P2860
P304
P356
10.2174/138920109787315060
P577
2009-02-01T00:00:00Z